152 related articles for article (PubMed ID: 26252229)
1. Synthesis and Evaluation as Prodrugs of Hydrophilic Carbamate Ester Analogues of Resveratrol.
Azzolini M; Mattarei A; La Spina M; Marotta E; Zoratti M; Paradisi C; Biasutto L
Mol Pharm; 2015 Sep; 12(9):3441-54. PubMed ID: 26252229
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro/in vivo evaluation of novel oral N-alkyl- and N,N-dialkyl-carbamate esters of entacapone.
Savolainen J; Leppanen J; Forsberg M; Taipale H; Nevalainen T; Huuskonen J; Gynther J; Mannisto PT; Jarvinen T
Life Sci; 2000; 67(2):205-16. PubMed ID: 10901288
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs of scutellarin: ethyl, benzyl and N,N-diethylglycolamide ester synthesis, physicochemical properties, intestinal metabolism and oral bioavailability in the rats.
Cao F; Guo JX; Ping QN; Liao ZG
Eur J Pharm Sci; 2006 Dec; 29(5):385-93. PubMed ID: 16997537
[TBL] [Abstract][Full Text] [Related]
4. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
5. Carbamate ester prodrugs of dopaminergic compounds: synthesis, stability, and bioconversion.
Hansen KT; Faarup P; Bundgaard H
J Pharm Sci; 1991 Aug; 80(8):793-8. PubMed ID: 1686464
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
[TBL] [Abstract][Full Text] [Related]
7. (Acyloxy)alkyl carbamate prodrugs of norfloxacin.
Alexander J; Fromtling RA; Bland JA; Pelak BA; Gilfillan EC
J Med Chem; 1991 Jan; 34(1):78-81. PubMed ID: 1992156
[TBL] [Abstract][Full Text] [Related]
8. Stability studies of some glycolamide ester prodrugs of niflumic acid in aqueous buffers and human plasma by HPLC with UV detection.
Talath S; Shirote PJ; Lough WJ; Gadad AK
Arzneimittelforschung; 2006; 56(9):631-9. PubMed ID: 17063638
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological activity and hydrolysis behavior of novel ibuprofen glucopyranoside conjugates.
Zhao X; Tao X; Wei D; Song Q
Eur J Med Chem; 2006 Nov; 41(11):1352-8. PubMed ID: 16806590
[TBL] [Abstract][Full Text] [Related]
10. In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media.
Hirayama F; Minami K; Uekama K
J Pharm Pharmacol; 1996 Jan; 48(1):27-31. PubMed ID: 8722490
[TBL] [Abstract][Full Text] [Related]
11. Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration.
Minami K; Hirayama F; Uekama K
J Pharm Sci; 1998 Jun; 87(6):715-20. PubMed ID: 9607948
[TBL] [Abstract][Full Text] [Related]
12. Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid.
Khan MS; Akhter M
Pharmazie; 2005 Feb; 60(2):110-4. PubMed ID: 15739898
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats.
Ogiso T; Iwaki M; Tanino T; Nagai T; Ueda Y; Muraoka O; Tanabe G
Biol Pharm Bull; 1996 Sep; 19(9):1178-83. PubMed ID: 8889037
[TBL] [Abstract][Full Text] [Related]
14. Aqueous solubility and dissolution rate does not adequately predict in vivo performance: a probe utilizing some N-acyloxymethyl phenytoin prodrugs.
Stella VJ; Martodihardjo S; Rao VM
J Pharm Sci; 1999 Aug; 88(8):775-9. PubMed ID: 10430541
[TBL] [Abstract][Full Text] [Related]
15. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery.
Uekama K; Minami K; Hirayama F
J Med Chem; 1997 Aug; 40(17):2755-61. PubMed ID: 9276021
[TBL] [Abstract][Full Text] [Related]
16. Importance of hydrolysis of amino acid moiety in water-soluble prodrugs of disodium cromoglycate for increased oral bioavailability.
Yoshimi A; Hashizume H; Tamaki S; Tsuda H; Fukata F; Nishimura K; Yata N
J Pharmacobiodyn; 1992 Jul; 15(7):339-45. PubMed ID: 1447681
[TBL] [Abstract][Full Text] [Related]
17. Factor VIIa inhibitors: a prodrug strategy to improve oral bioavailability.
Riggs JR; Kolesnikov A; Hendrix J; Young WB; Shrader WD; Vijaykumar D; Stephens R; Liu L; Pan L; Mordenti J; Green MJ; Sukbuntherng J
Bioorg Med Chem Lett; 2006 Apr; 16(8):2224-8. PubMed ID: 16458507
[TBL] [Abstract][Full Text] [Related]
18. Natural Amino Acid-Bearing Carbamate Prodrugs of Daidzein Increase Water Solubility and Improve Phase II Metabolic Stability for Enhanced Oral Bioavailability.
Li Y; Liu X; Lu F; Li H; Zhang J; Zhang Y; Li W; Wang W; Yang M; Ma Z; Zhang H; Zhou X; Xu Y; He Z; Sun J; Zhang T; Jiang Q
J Agric Food Chem; 2024 Apr; 72(15):8618-8631. PubMed ID: 38569082
[TBL] [Abstract][Full Text] [Related]
19. Absorption of ester prodrugs in Caco-2 and rat intestine models.
He X; Sugawara M; Takekuma Y; Miyazaki K
Antimicrob Agents Chemother; 2004 Jul; 48(7):2604-9. PubMed ID: 15215116
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds.
Chan OH; Schmid HL; Stilgenbauer LA; Howson W; Horwell DC; Stewart BH
Pharm Res; 1998 Jul; 15(7):1012-8. PubMed ID: 9688053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
